ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Alignment Health Plan Recognized as One of Two Medicare Advantage Prescription Drug Plans in the U.S. for Excellence in Pharmacy Quality

ORANGE, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) has been recognized for excellence in quality for its Medicare Advantage prescription drug (MAPD) plan by the Pharmacy Quality Alliance (PQA). The PQA has measured medication safety for the Centers for Medicare and Medicaid Services (CMS) since 2006, ensuring medication safety, adherence and appropriate use. Out of 633 eligible contracts, only 1.3% achieved recognition, highlighting the significance of this award.

“We are incredibly honored to be one of only two MAPD plans recognized by PQA for our unwavering focus on quality and consistency in achieving medication adherence,” said Dawn Maroney, CEO, Alignment Health Plan. “This award reaffirms our mission-driven approach to combine personalized care and commitment to improving outcomes for the seniors we serve to live a healthier lifestyle.”

The 2025 PQA Laura Cranston Excellence in Quality Award goes to MAPDs with at least a 4.5-star Part D summary rating and a perfect 5-star rating on all five PQA medication measures used in CMS’s star ratings program. Alignment Health was one of two MAPDs that earned the perfect rating on the following five PQA measures: medication adherence for diabetes medications; medication adherence for hypertension (RAS antagonists); medication adherence for cholesterol (statins); medication therapy management program completion rate for comprehensive medication reviews; and statin use in persons with diabetes. CMS evaluates Medicare plan quality every year based on a 5-star rating system.

Alignment’s MAPD plans provide prescription drug coverage with personalized support to help members access the medicine they need to stay healthy, particularly those managing multiple chronic conditions.

“We are immensely proud of our team's dedication to advancing pharmacy care,” said Ruby Liu, vice president of pharmacy, Alignment Health. “Medication adherence can be a hurdle for seniors. To address that, Alignment has invested in quality through tested processes, predictive technology and personalized concierge support for our members. This commitment enhances patient health and well-being while also reducing costs for both our members and the organization.”

Alignment Health Plan received the PQA Excellence in Quality Award from 2018 to 2022 and the PQA Quality Improvement Award in 2018, becoming the first health plan to receive both PQA awards in the same year. This is the sixth time Alignment has received this honor.

The PQA has recognized Medicare prescription drug plans for their achievements in medication safety since 2011. Alignment will accept the award at the 2025 PQA Annual Meeting on May 20 in Tampa, Florida.

About Alignment Health
Alignment Health is championing a new path in senior care that empowers members to age well and live their most vibrant lives. A consumer brand name of Alignment Healthcare (NASDAQ: ALHC), Alignment Health’s mission-focused team makes high-quality, low-cost care a reality for its Medicare Advantage members every day. Based in California, the company partners with nationally recognized and trusted local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology, AVA®. As it expands its offerings and grows its national footprint, Alignment upholds its core values of leading with a serving heart and putting the senior first. For more information, visit www.alignmenthealth.com.

Media Contact
Priya Shah
mPR, Inc. for Alignment Health
alignment@mpublicrelations.com


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.